Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
about
Glucagon orchestrates stress-induced hyperglycaemiaThe potential role of incretin therapy in the hospital setting.American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured beta cells.Bench-to-bedside review: the gut as an endocrine organ in the critically illThe therapeutic potential of a venomous lizard: the use of glucagon-like peptide-1 analogues in the critically illExogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes.Hyperglycemia in acute ischemic stroke: a vascular perspective.Maintaining a physiological blood glucose level with 'glucolevel', a combination of four anti-diabetes plants used in the traditional arab herbal medicine.EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET β CELL IN VITRO.Ginseng on hyperglycemia: effects and mechanismsIncretin-based therapies: new treatments for type 2 diabetes in the new millennium.Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge.Waking up the gut in critically ill patients.The role of nitric oxide synthase in post-operative hyperglycaemia.Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients.Glucose metabolism in critically ill patients: are incretins an important player?The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins.Nutrition and Hyperglycemia Management in the Inpatient Setting (Meals on Demand, Parenteral, or Enteral Nutrition).American ginseng modulates pancreatic beta cell activities.Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models.Diabesity: an overview of a rising epidemic.
P2860
Q28068879-24DAFF6D-FC30-4210-A266-58F59C6F022FQ33792390-F6FD44B8-3A10-412E-B1EB-CF28BE3F12E8Q34803578-63219219-AD2E-4F94-A9C4-99ED97210701Q35559137-D2EDCE87-2DA8-4F53-B378-17BD2A377F1AQ35559222-EA100013-81A0-4682-A107-D2D88306B4AEQ35567284-197F22FB-8CBB-4D32-B040-7123EE99EAF5Q36521250-17EAAD25-A809-48E9-ADF2-F9CC916620CBQ36981112-33871612-8AB9-42E3-B0FD-856EB5BE165CQ37191153-B9CA4A5E-14BF-44B0-ACC8-B891B2836741Q37309905-7350ACBD-0F5E-4498-8EC7-A494244E36E1Q37316259-39597017-9CCE-40B6-8448-44891FADE1DBQ37780914-F46394D5-675F-41CC-B2AE-923B1B37A164Q37795946-2FD0E877-AA9C-461B-81F1-21AC92C71F84Q37868424-CE543D19-45FB-4E94-AE86-3F0232741E73Q37971830-C9641E3C-2449-4BB7-9FD2-C5E1ACE338BDQ38142955-7D0A803C-D4DA-42BD-AB57-B95610A139D8Q38187004-AEABAD88-51FD-4D1B-A2B8-E7DC48E23930Q39406219-5BDD5AC5-6716-4D54-8F6D-5B1F3A5A642EQ40660633-2FB43163-3BE1-46EC-A3E7-51E1AFAFD2F2Q46772282-6C459684-B426-4877-B273-EB7105FA12F3Q48970248-BDE17F9E-3599-4C4F-8280-BFF897D20196
P2860
Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Blood glucose control in healt ...... using glucagon-like peptide 1.
@en
Blood glucose control in healt ...... using glucagon-like peptide 1.
@nl
type
label
Blood glucose control in healt ...... using glucagon-like peptide 1.
@en
Blood glucose control in healt ...... using glucagon-like peptide 1.
@nl
prefLabel
Blood glucose control in healt ...... using glucagon-like peptide 1.
@en
Blood glucose control in healt ...... using glucagon-like peptide 1.
@nl
P2093
P1433
P1476
Blood glucose control in healt ...... using glucagon-like peptide 1.
@en
P2093
Andrea El-Ouaghlidi
Arndt Vethacke
Baptist Gallwitz
Jörg Walberg
Metin Senkal
Michael A Nauck
W Schmiegel
Wolfgang E Schmidt
P356
10.1016/J.REGPEP.2003.11.003
P577
2004-04-01T00:00:00Z